Identifying risky behaviors: The key to HIV prevention

July 11, 2012

HIV prevention must be better targeted, according to David Holtgrave from Johns Hopkins Bloomberg School of Public Health in the US, and colleagues. Health care professionals need a more detailed analysis and understanding of the interplay between HIV risk behavior, access to treatment and treatment success among those living with HIV. The authors discuss their proposed framework in a study¹ in a special issue of Springer's journal AIDS and Behavior. The special issue, "Turning the Tide Together: Advances in Behavioral Interventions Research"² is freely available online and will be published in July to coincide with the XIX International AIDS Conference in Washington, DC, from 22 – 27 July 2012.

The National Institutes of Health recently reported a major breakthrough in the fight against . Research showed that treating individuals with HIV with anti-retroviral therapy—so called 'treatment as prevention'—could reduce the risk of transmission of the virus to healthy heterosexual partners by up to 96 percent. Although these results have been heralded as "the beginning of the end of AIDS," the research finds that this treatment needs to take a wider perspective and consider the full range of HIV-risk behaviors.

Holtgrave and colleagues' paper identifies the critical role that HIV-related plays in determining the ultimate impact of treatment as prevention. The authors describe the size of the population at risk for HIV and identify three subgroups of people living with the disease. These subgroups include: those who are unaware of their serostatus; those who are aware of their status and do not engage in risky behavior; and those who are aware of their serostatus and are engaging in risky behavior. While all of the subgroups may transmit the virus, they vary considerably in terms of awareness of their serostatus and risk behaviors, as well as the rate at which they could transmit HIV.

For each of these subgroups the researchers identified the most relevant approach: 'testing and linkage to care'; 'treatment as prevention'; and/or 'treatment as clinical care'. They note that the impact ' as prevention' might have on the spread of HIV will depend heavily on which subgroup is targeted for this approach.

The authors conclude, "The framework we describe helps us to move more toward 'complementary prevention' in which the best interventions from all domains are chosen to address clients' specific clinical needs and to address public health needs of averting new infections. needs an approach that is truly synergistic, resulting in an effect that is more than the sum of the intervention's parts."

Explore further: New book on HIV from Cold Spring Harbor Laboratory Press

More information: 1. Holtgrave DR et al (2012). Behavioral factors in assessing impact of HIV treatment as prevention. AIDS and Behavior; DOI 10.1007/s10461-012-0186-1. Available at http://dx.doi.org/10.1007/s10461-012-0186-1

2. The special July 2012 issue of AIDS and Behavior "Turning the Tide Together: Advances in Behavioral Interventions Research" is freely available to the general public at www.springerlink.com/content/1090-7165/16/5/

Related Stories

New book on HIV from Cold Spring Harbor Laboratory Press

December 15, 2011
The worldwide AIDS epidemic makes research on HIV, the disease processes it induces, and potential HIV therapies among the most critical in biomedical science. Furthermore, the basic biology of HIV infections provides a model ...

DC Female Condom program highly effective in preventing HIV infections

March 26, 2012
A new economic analysis, conducted by Johns Hopkins Bloomberg School of Public Health and featured in the current issue of Springer's journal AIDS and Behavior, showed that the DC Female Condom program, a public-private partnership ...

Investigating the impact of treatment on new HIV infections: New PLoS collection

July 10, 2012
Is it possible to cut HIV transmission by using antiretroviral treatment? A collection of new articles published in the open-access journal PLoS Medicine, in conjunction with the HIV Modelling Consortium, addresses this pressing ...

Key goals for building on 30 years of HIV/AIDS research

May 31, 2011
In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease. Now the challenge, according to ...

Improving care of HIV-positive young men of color who have sex with men

August 16, 2011
To overcome the unique challenges faced by a growing segment of the HIV-positive population—young men of color who have sex with men (YMSM of Color)—novel intervention strategies for providing HIV testing, medical ...

Recommended for you

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.